- Home
- GSIW vs GTBP Comparison
GSIW vs GTBP Comparison
Compare GSIW & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSIW | GTBP |
|---|---|---|
| Founded | 2016 | 1965 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 12.1M |
| IPO Year | 2022 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GSIW | GTBP |
|---|---|---|
| Price | $15.28 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 566.2K | ★ 662.0K |
| Earning Date | 01-01-0001 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.75 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.39 |
| 52 Week High | $36.90 | $3.73 |
Technical Indicators
Market Signals| Indicator | GSIW | GTBP |
|---|---|---|
| Relative Strength Index (RSI) | 61.37 | 37.94 |
| Support Level | $0.11 | $0.40 |
| Resistance Level | $36.90 | $0.59 |
| Average True Range (ATR) | 4.06 | 0.03 |
| MACD | 0.43 | 0.01 |
| Stochastic Oscillator | 44.67 | 36.07 |
Price Performance
Historical ComparisonAbout GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.